课题基金 / 基金详情

Economic Evaluation of Early Intervention with anti-Tumour Necrosis Factor Alpha Medications in Children with Crohn's disease

Economic Evaluation of Early Intervention with anti-Tumour Necrosis Factor Alpha Medications in Children with Crohn's disease
克罗恩病儿童抗肿瘤坏死因子α药物早期干预的经济评价
批准号:
313976
负责人:
Ungar Wendy J
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-05-01 至 2015-05-01

项目摘要

项目成果

Ungar Wendy J的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Crohn's disease (CD) is a type of inflammatory bowel disease (IBD) that is increasingly common in Canadian children. The annual cost-of-illness of pediatric IBD is conservatively estimated at $70 million. The treatment of pediatric CD is complex, involvin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canada Research Chair - Tier 1
  • 批准号:
    404354
  • 项目类别:
  • 资助金额:
    $101.99万
  • 财政年份:
    2018
  • 负责人:
    Ungar Wendy J
  • 依托单位:
Thiopurine S-methyltransferase testing for averting drug toxicity in pediatric patients receiving thiopurines: An application of enhanced meta-analysis of diagnostic tests
  • 批准号:
    285225
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.22万
  • 财政年份:
    2013
  • 负责人:
    Ungar Wendy J
  • 依托单位:
海外基金